liu.seSearch for publications in DiVA
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Antidepressant use in Australia and Sweden-A cross-country comparison
Linköpings universitet, Institutionen för hälsa, medicin och vård. Linköpings universitet, Medicinska fakulteten.
Univ Queensland, Australia.
Linköpings universitet, Institutionen för hälsa, medicin och vård, Avdelningen för prevention, rehabilitering och nära vård. Linköpings universitet, Medicinska fakulteten. Region Östergötland, Primärvårdscentrum, Vårdcentralen Kärna.
Univ Queensland, Australia.
Vise andre og tillknytning
2021 (engelsk)Inngår i: Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, E-ISSN 1099-1557, Vol. 30, nr 4, s. 409-417Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Purpose To compare the dispensed use of antidepressants in Australia and Sweden. Methods We analysed publicly available data from Australia and Sweden on dispensed use of antidepressants from 2006 to 2018. Results The dispensed use of antidepressants has increased in both Australia and Sweden. Australia had a more rapid increase resulting in a higher total use. The utilisation profile was similar in both countries; SSRIs were the most commonly used group, "other antidepressants" were the group that increased the most, and seven of the eight most used substances were the same. There were differences in which antidepressants were most used, with the three most prescribed antidepressants being escitalopram, sertraline, and venlafaxine in Australia; and mirtazapine, sertraline, and citalopram in Sweden. Conclusion Dispensed use of antidepressants has increased remarkably in both Australia and Sweden between 2006 and 2018. Although similar with regard to economic status and health care system, use of antidepressants differs between both countries. This may be a result of a combination of factors related to medical, contextual and policy evidence. The differences displayed in this study may reflect varying accessibility of treatments, national programmes enhancing mental health literacy in the population, clinical prescribing guidelines and timing of approval of new antidepressants.

sted, utgiver, år, opplag, sider
WILEY , 2021. Vol. 30, nr 4, s. 409-417
Emneord [en]
antidepressant agent; Australia; drug utilisation; pharmacoepidemiology; prescription; Sweden
HSV kategori
Identifikatorer
URN: urn:nbn:se:liu:diva-171712DOI: 10.1002/pds.5158ISI: 000587641600001PubMedID: 33098321OAI: oai:DiVA.org:liu-171712DiVA, id: diva2:1505267
Tilgjengelig fra: 2020-11-30 Laget: 2020-11-30 Sist oppdatert: 2025-02-20

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMed

Søk i DiVA

Av forfatter/redaktør
Eek, EmmaFalk, Magnus
Av organisasjonen
I samme tidsskrift
Pharmacoepidemiology and Drug Safety

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 102 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf